It doesnt matter, Coz Bubs still makes loss this year. Even if its projected Revenue $50M next year, BUBS HAS very thins profits. Let along with ITS CFDA APPLICATION which is far way behind its original schedule. (Please read its FY17 annual report, it clearly states it should be lodged in 2nd Q 2018)
Even more ridiculous, Bubs brand reputation is still very low in China one year after FY17.
Surely, The management team nailed several milestone stages in the past months, however, i didn't see their passion to win this market. If so, they should take aggressively actions, such as submitted CFDA last year or signed a deal with Tmall last year. The process is very slow very slow.
They spent 0.97M in advertising, where did it go? Did u see advertisement in Australia or in China?
- Forums
- ASX - By Stock
- BUB
- Bubs FY19 $50M
Bubs FY19 $50M, page-7
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.005(3.70%) |
Mkt cap ! $124.8M |
Open | High | Low | Value | Volume |
13.5¢ | 14.0¢ | 13.0¢ | $179.2K | 1.328M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 1958180 | 13.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 961442 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
22 | 1958180 | 0.130 |
51 | 3829215 | 0.125 |
67 | 3909216 | 0.120 |
28 | 1681963 | 0.115 |
34 | 813126 | 0.110 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 961442 | 25 |
0.145 | 521511 | 17 |
0.150 | 1005594 | 31 |
0.155 | 164334 | 10 |
0.160 | 190718 | 11 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online